Skip to main content

Sklamberg’s Predicted Rescheduling of Cannabis Confirmed in Recent HHS Recommendation

September 15, 2023

Life Sciences & Healthcare Regulatory partner Howard Sklamberg was featured in numerous publications — including CNN, The Washington Post, MarketWatch, MJBizDaily, Marijuana Moment, KNX News On Demand, Ars Technica, and mg Magazine — regarding the U.S. Department of Health and Human Services’ recent recommendation to move cannabis from Schedule I to Schedule III under federal law.

Sklamberg, who noted the possibility of the rescheduling in previous articles, said he expects the U.S. Drug Enforcement Agency to issue a proposed rule sometime in the coming months and that cannabis could officially be moved to Schedule III by the first half of 2024.

In discussing the possible impacts of a proposed rule, Sklamberg told Ars Technica that a rule “could make it easier in some states to legalize and decriminalize” cannabis.

» Read the MJBizDaily article: “Once a marijuana enemy, DEA now key to rescheduling.”
» Read the MarketWatch article: “Opinion: Cannabis stocks are still a buy despite recent double-digit gains.”
» Read the Marijuana Moment article: “GOP Congressman Worries That Moving Marijuana To Schedule III Could ‘Allow Big Pharma To Control It.’”
» Read the Marijuana Moment article: “Moving Marijuana To Schedule III Could Have Sweeping Impacts For Businesses, Federal Employees, Research And More.”
» Listen to the KNX News On Demand podcast: “The feds rescheduling marijuana is a small step towards national decriminalization ... and could make life easier for California pot growers.”
» Read The Washington Post article: “Possible Easing of Marijuana Restrictions Could Have Major Implications.”
» Read the Marijuana Moment article: “Federal Review Officially Recommends Moving Cannabis to Schedule III.”
» Read the Ars Technica article: “Federal health dept. says marijuana should be downgraded to Schedule 3 drug.”
» Read the CNN article: “HHS official calls for reclassifying marijuana as a lower-risk drug in letter sent to DEA.”
» Read The Washington Post article: “Federal health agency recommends easing marijuana restrictions.”
» Read the mg Magazine article: “U.S. Health Officials Recommend Schedule III for Cannabis.”